HighVista Strategies’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.36M	Sell	2,598 -241	-8%	-$115K	0.38%	85
2025 Q4	$1.65M	Sell	2,839 -698	-20%	-$357K	0.43%	65
2025 Q3	$1.62M	Buy	3,537 +1,232	+53%	+$460K	0.4%	79
2025 Q2	$698K	Buy	2,305 +94	+4%	+$28K	0.26%	116
2025 Q1	$732K	Hold	2,211	–	–	0.28%	119
2024 Q4	$682K	Hold	2,211	–	–	0.25%	117
2024 Q3	$469K	Sell	2,211 -323	-13%	-$82.6K	0.16%	133
2024 Q2	$710K	Hold	2,534	–	–	0.26%	108
2024 Q1	$677K	Buy	2,534 +1,103	+77%	+$260K	0.24%	108
2023 Q4	$331K	Sell	1,431 -1,614	-53%	-$282K	0.12%	124
2023 Q3	$445K	Buy	3,045 +249	+9%	+$46.9K	0.21%	120
2023 Q2	$646K	Hold	2,796	–	–	0.3%	110
2023 Q1	$677K	Buy	+2,796	New	+$762K	0.55%	63
2022 Q4	–	Sell	-9,527	Closed	-$619K	–	117
2022 Q3	$619K	Buy	9,527 +4,727	+98%	+$328K	0.35%	74
2022 Q2	$344K	Buy	4,800 +275	+6%	+$20.2K	0.21%	88
2022 Q1	$444K	Buy	+4,525	New	+$382K	0.28%	76